Suppr超能文献

甲状腺眼病及其在 Academy IRIS 注册研究中的威胁视力表现:2014-2018 年。

Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.

机构信息

From Department of Oculoplastics and Orbital Surgery, Wills Eye Hospital, Philadelphia, PA, USA (S.R, R.P); The Center for Eye and Facial Plastic Surgery, Somerset, NJ, USA (S.R).

Vickie and Jack Farber Vision Research Center at Wills Eye Hospital, Philadelphia, PA, USA (Q.Z, J.S, L.H); Wills Eye Hospital, Department of Ophthalmology, Sidney Kimmel Medical Center at Thomas Jefferson University, Philadelphia, PA, USA (Q.Z, J.H, L.H).

出版信息

Am J Ophthalmol. 2023 Sep;253:74-85. doi: 10.1016/j.ajo.2023.04.013. Epub 2023 May 17.

Abstract

PURPOSE

To evaluate prevalence of thyroid eye disease (TED) and associated factors in the American Academy of Ophthalmology IRIS Registry (Intelligent Research in Sight).

DESIGN

Cross-sectional analysis of the IRIS Registry.

METHODS

IRIS Registry patients (18-90 years old) were classified as TED (ICD-9: 242.00, ICD-10: E05.00 on ≥2 visits) or non-TED cases, and prevalence was estimated. Odds ratios (OR) and 95% Confidence Intervals (CIs) were estimated using logistic regression.

RESULTS

41,211 TED patients were identified. TED prevalence was 0.09%, showed a unimodal age distribution (highest prevalence in ages 50-59 years (y) (0.12%)), higher rates in females than males (0.12% vs. 0.04%) and in non-Hispanics than Hispanics (0.10% vs. 0.05%). Prevalence differed by race (from 0.08% in Asians to 0.12% in Black/African-Americans), with varying peak ages of prevalence. Factors associated with TED in multivariate analysis included age: ((18-<30y (reference), 30-39y: OR (95%CI) 2.2 (2.0, 2.4), 40-49y: 2.9 (2.7,3.1), 50-59y: 3.3 (3.1, 3. 5), 60-69y: 2.7 (2.54, 2.85), 70+: 1.5 (1.46, 1.64)); female sex vs male (reference), 3.5 (3.4,3.6), race: White (reference), Blacks: 1.1 (1.1,1.2), Asian: 0.9 (0.8,0.9), Hispanic ethnicity vs not Hispanic (reference), 0.68 (0.6,0.7), smoking status: (never (ref), former: 1.64 (1.6,1.7), current 2.16: (2.1,2.2)) and Type 1 diabetes (yes vs no (reference): 1.87 (1.8, 1.9).

CONCLUSIONS

This epidemiologic profile of TED includes new observations such as a unimodal age distribution and racial variation in prevalence. Associations with female sex, smoking, and Type 1 diabetes are consistent with prior reports. These findings raise novel questions about TED in different populations.

摘要

目的

评估美国眼科学会 IRIS 注册中心(智能眼科研究)中甲状腺眼病(TED)的患病率及其相关因素。

设计

IRIS 注册中心的横断面分析。

方法

将 IRIS 注册中心的患者(18-90 岁)分为 TED(ICD-9:242.00,ICD-10:E05.00 在≥2 次就诊时)或非 TED 病例,并估计患病率。使用逻辑回归估计比值比(OR)和 95%置信区间(CI)。

结果

共确定了 41,211 例 TED 患者。TED 的患病率为 0.09%,呈单峰年龄分布(50-59 岁年龄组(y)的患病率最高(0.12%)),女性患病率高于男性(0.12%比 0.04%),非西班牙裔人群患病率高于西班牙裔人群(0.10%比 0.05%)。患病率因种族而异(从亚洲的 0.08%到黑人/非裔美国人的 0.12%),不同种族的患病率峰值年龄也不同。多变量分析中与 TED 相关的因素包括年龄:((18-<30y(参考),30-39y:OR(95%CI)2.2(2.0,2.4),40-49y:2.9(2.7,3.1),50-59y:3.3(3.1,3. 5),60-69y:2.7(2.54,2.85),70+岁:1.5(1.46,1.64));女性性别与男性(参考),3.5(3.4,3.6),种族:白人(参考),黑人:1.1(1.1,1.2),亚洲人:0.9(0.8,0.9),西班牙裔种族与非西班牙裔种族(参考),0.68(0.6,0.7),吸烟状况:(从不(参考),以前:1.64(1.6,1.7),现在:2.16:(2.1,2.2))和 1 型糖尿病(是与否(参考):1.87(1.8,1.9)。

结论

该 TED 流行病学特征包括新的观察结果,如单峰年龄分布和患病率的种族差异。与女性、吸烟和 1 型糖尿病相关的关联与先前的报告一致。这些发现提出了关于不同人群中 TED 的新问题。

相似文献

6
Bilateral versus unilateral thyroid eye disease.双侧与单侧甲状腺眼病。
Indian J Ophthalmol. 2011 Sep-Oct;59(5):363-6. doi: 10.4103/0301-4738.83612.

引用本文的文献

1
The burden of illness in thyroid eye disease: current state of the evidence.甲状腺眼病的疾病负担:证据现状
Front Ophthalmol (Lausanne). 2025 Apr 17;5:1565762. doi: 10.3389/fopht.2025.1565762. eCollection 2025.

本文引用的文献

7
Thyroid eye disease: what is new to know?甲状腺眼病:有哪些新的认识?
Curr Opin Ophthalmol. 2018 Nov;29(6):528-534. doi: 10.1097/ICU.0000000000000529.
8
Phenotypes of Thyroid Eye Disease.甲状腺眼病的表型
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S28-S33. doi: 10.1097/IOP.0000000000001147.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验